The largest database of trusted experimental protocols

Crystal violet assay

Manufactured by Abcam
Sourced in United Kingdom

The Crystal Violet Assay is a colorimetric method used to quantify the number of viable cells in a sample. The assay relies on the ability of viable cells to take up and bind the crystal violet dye. The amount of dye retained is proportional to the number of viable cells present, which can be measured by absorbance at a specific wavelength.

Automatically generated - may contain errors

4 protocols using crystal violet assay

1

Cell Invasion Assay with PAD Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell invasion assay was performed according to previous methods described in detail elsewhere [17 (link),117 (link)]. Briefly, 5 × 105 cells (treated with pan-PAD inhibitor Cl-amidine and the PAD isozyme-specific inhibitors with respective PBS or DMSO control as before) were plated on Matrigel-coated transwell filters (Corning™ BioCoat™ Matrigel™ Invasion Chamber with Corning™ Matrigel Matrix; BD Biosciences, Wokingham, UK) in a chemotactic gradient of 1:10% FBS. Following an incubation time of 16 h, the number of invaded cells was determined using the crystal violet assay (Abcam, U.K.) and the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay (Abcam, U.K.). The same number of cells was plated and incubated in parallel for 16 h, for assessment of PAD inhibitor-mediated effects on cell proliferation. The CLARIOstar plate reader (BMG Labtech, Aylesbury, UK) was used at 540–590 nm to measure absorbance and normalised according to the control. The experiments were performed in three biological and three technical repeats.
+ Open protocol
+ Expand
2

Quantifying Staphylococcus aureus Biofilm

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five mice in each group underwent whole blood collection as above. One-hundred microliters of whole blood from each mouse were mixed with 100 μL of 1 × 107S. aureus Xen36 CFU/mL for a final inoculum of 106 CFU in 200 μL. This solution was added to each well within a 96-well-flat bottom plate. Six additional control wells containing 200 μL of saline were also included for standardization. After 24 h of incubation at 37°C, each well was washed with PBS three times to remove residual blood cells and non-adherent bacteria. A well-validated crystal violet assay (Abcam, Cambridge, United Kingdom) (62 (link)–64 (link)) was performed to quantify the biomass of the residual biofilm formation by OD at 595 nm.
+ Open protocol
+ Expand
3

Quantifying S. aureus Biofilm Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six mice in each group underwent whole blood collection as above. 100 μL of 1 x 107S. aureus Xen36 CFU/mL and 100 μL of blood from each mouse were mixed into each well of a 96-well flat bottom plate. Additionally, 200 μL of saline was used as a standardized control. The plate was incubated for 24 hours at 37°C (MaxQ 4450; ThermoFisher Scientific) to permit sufficient biofilm formation. Wells were then washed with PBS three times to remove blood and non-adherent bacteria. In order to quantify mass of the residual biofilm, a well-validated crystal violet assay (Abcam, Cambridge, United Kingdom) was performed and absorbance was measured by OD at 595nm (FLUOstar Omega, BMG Labtech, Ortenberg Germany). Values were reported as absorbance units.
+ Open protocol
+ Expand
4

Evaluating Cell Invasion Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell invasion assay was performed as previously described in detail [143 (link)]. Briefly, 5 × 105 cells (treated with the PAD isozyme-specific inhibitors or DMSO control as before) were plated on Matrigel-coated transwell filters (Corning™ BioCoat™ Matrigel™ Invasion Chamber with Corning™ Matrigel Matrix; BD Biosciences, Wokingham, Berkshire, U.K.) in a chemotactic gradient of 1:10% FBS. After 16 h incubation, the total number of invaded cells was determined by MTT assay (Abcam, Cambridge, U.K.) and further confirmed by crystal violet assay (Abcam, U.K.). In parallel, the same number of cells was plated and incubated for 16 h to determine the effect of the PAD isozyme-specific inhibitors on cell proliferation by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. Absorbance was measured using CLARIOstar plate reader (BMG Labtech, Aylesbury, U.K.) at 540–590 nm and normalised according to the control. The experiments were performed in 3 biological and 3 technical repeats.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!